Business Description
Burning Rock Biotech Ltd
ISIN : US12233L1070
Share Class Description:
BNR: ADRDescription
Burning Rock Biotech Ltd is a cancer diagnostics company. Its products include OncoScreen Plus and ColonCore. The company has developed various cancer detection products, involving tumor targeting, differentiation of benign and malignant tumors, monitoring of small residual lesions, prediction of tumor recurrence progress, and detection of tumor sensitivity. It offers 12 NGS-based cancer therapy selection tests comprising a broad range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer, using both tissue and liquid biopsy samples.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 33.33 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | -4.06 | |||||
| Beneish M-Score | -3.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.4 | |||||
| 3-Year EBITDA Growth Rate | -77.3 | |||||
| 3-Year EPS without NRI Growth Rate | -69.5 | |||||
| 3-Year FCF Growth Rate | -17.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.05 | |||||
| 9-Day RSI | 61.82 | |||||
| 14-Day RSI | 57.11 | |||||
| 6-1 Month Momentum % | -37.61 | |||||
| 12-1 Month Momentum % | -76.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.28 | |||||
| Quick Ratio | 2.98 | |||||
| Cash Ratio | 2.16 | |||||
| Days Inventory | 248.1 | |||||
| Days Sales Outstanding | 81.27 | |||||
| Days Payable | 82.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 7.32 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 69.19 | |||||
| Operating Margin % | -129.12 | |||||
| Net Margin % | -126.86 | |||||
| FCF Margin % | -55.31 | |||||
| ROE % | -66.25 | |||||
| ROA % | -48.84 | |||||
| ROIC % | -148.1 | |||||
| ROC (Joel Greenblatt) % | -269.56 | |||||
| ROCE % | -64.88 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.93 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.7 | |||||
| EV-to-EBIT | 0.06 | |||||
| EV-to-EBITDA | 0.06 | |||||
| EV-to-Revenue | -0.08 | |||||
| EV-to-FCF | -0.04 | |||||
| Price-to-Net-Current-Asset-Value | 0.9 | |||||
| Price-to-Net-Cash | 1.78 | |||||
| Earnings Yield (Greenblatt) % | 1666.67 | |||||
| FCF Yield % | -53.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BNR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Burning Rock Biotech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 78.988 | ||
| EPS (TTM) ($) | -0.979 | ||
| Beta | 0.68 | ||
| Volatility % | 44.21 | ||
| 14-Day RSI | 57.11 | ||
| 14-Day ATR ($) | 0.076691 | ||
| 20-Day SMA ($) | 0.73516 | ||
| 12-1 Month Momentum % | -76.22 | ||
| 52-Week Range ($) | 0.5722 - 3.25 | ||
| Shares Outstanding (Mil) | 102.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Burning Rock Biotech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Burning Rock Biotech Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Burning Rock Biotech Ltd Frequently Asked Questions
What is Burning Rock Biotech Ltd(BNR)'s stock price today?
The current price of BNR is $0.80. The 52 week high of BNR is $3.25 and 52 week low is $0.57.
When is next earnings date of Burning Rock Biotech Ltd(BNR)?
The next earnings date of Burning Rock Biotech Ltd(BNR) is 2024-05-30 Est..
Does Burning Rock Biotech Ltd(BNR) pay dividends? If so, how much?
Burning Rock Biotech Ltd(BNR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers